Hyperelongated biglycan: the surreptitious initiator of atherosclerosis

To outline a role for the dermatan sulfate proteoglycan biglycan and specifically its growth factor modified form having elongated glycosaminoglycan chains as being a primary initiator of atherosclerosis. Antiatherosclerotic therapies have mostly targeted epidemiologically identified, experimentally...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in lipidology Vol. 19; no. 5; p. 448
Main Authors Little, Peter J, Osman, Narin, O'Brien, Kevin D
Format Journal Article
LanguageEnglish
Published England 01.10.2008
Subjects
Online AccessGet more information

Cover

Loading…